REGENXBIO, Inc.
(NASDAQ : RGNX)

( )
RGNX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.37%86.271.3%$1352.68m
AMGNAmgen Inc.
0.97%203.881.2%$612.82m
GILDGilead Sciences, Inc.
0.77%69.180.9%$531.67m
LOXOLoxo Oncology Inc
0.11%233.5012.7%$525.80m
BIIBBiogen Inc.
-0.27%337.421.3%$408.79m
VRTXVertex Pharmaceuticals Incorporated
2.19%194.701.9%$323.01m
ILMNIllumina, Inc.
0.87%312.753.5%$317.65m
REGNRegeneron Pharmaceuticals, Inc.
0.35%418.842.6%$300.57m
ALXNAlexion Pharmaceuticals, Inc.
2.12%117.052.0%$212.97m
TSROTESARO, Inc.
0.03%74.9614.4%$167.91m
INCYIncyte Corporation
-0.32%78.422.5%$149.05m
AAgilent Technologies, Inc.
2.10%72.311.5%$147.46m
EXASExact Sciences Corporation
4.19%78.8025.3%$141.72m
SRPTSarepta Therapeutics, Inc.
1.22%122.8015.4%$135.00m
LGNDLigand Pharmaceuticals Incorporated
6.49%117.9023.1%$126.49m

Company Profile

REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.